Advertisement

Topics

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Revision: 45, Authorised

08:20 EDT 19 Oct 2016 | European Medicines Agency
This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Revision: 45, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Revision: 45, Authorised"

Quick Search
Advertisement